Multiple endocrine neoplasia type 2 laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
| style="background: #B8B8B8; padding: 5px;"| Elevated norepinephrine<br>Elevated metanephrine<br>Elevated vanillylmandelic acid | | style="background: #B8B8B8; padding: 5px;"| Elevated norepinephrine<br>Elevated metanephrine<br>Elevated vanillylmandelic acid | ||
|} | |} | ||
==Reference== | |||
{{Reflist|2}} |
Revision as of 14:58, 25 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 laboratory findings |
FDA on Multiple endocrine neoplasia type 2 laboratory findings |
CDC on Multiple endocrine neoplasia type 2 laboratory findings |
Multiple endocrine neoplasia type 2 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 2 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory Tests
Test | Findings |
---|---|
Metabolic | Hypophosphatemia Hypercalcemia Elevated calcitonin Elevated epinephrine Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid Elevated parathyroid hormone Decreased serum phosphate Elevated pentagastrin |
Urinalysis | Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid |